Understanding how a specific protein affects nutrient sensing and blood sugar control in diabetes
Role of Hypoxia-inducible factor-2a in L-cell nutrient sensing and metabolic homeostasis
This study is looking at how a specific protein in your body helps control the release of a hormone that keeps your blood sugar in check, with the hope of finding new ways to improve diabetes treatment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11085098 on NIH RePORTER |
What this research studies
This research investigates the role of hypoxia-inducible factor-2α (HIF-2α) in the secretion of glucagon-like peptide-1 (GLP-1), a hormone that helps regulate blood sugar levels. By studying how dietary cues influence GLP-1 secretion through HIF-2α signaling in intestinal cells, the research aims to uncover new mechanisms that could improve diabetes treatment. The approach involves using animal models to observe changes in GLP-1 levels and related metabolic effects when HIF-2α is manipulated. The ultimate goal is to identify potential therapeutic targets that could enhance GLP-1 secretion without adverse effects commonly seen with current treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults with type 2 diabetes who are seeking better management options for their condition.
Not a fit: Patients with type 1 diabetes or those who do not have diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for type 2 diabetes that improve blood sugar control without causing gastrointestinal side effects.
How similar studies have performed: Previous studies have shown promising results in understanding GLP-1 secretion mechanisms, suggesting that this research could build on established findings.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Ramakrishnan, Sadeesh Kumar — University of Pittsburgh at Pittsburgh
- Study coordinator: Ramakrishnan, Sadeesh Kumar
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.